International Journal of Hematology

, Volume 73, Issue 1, pp 71–77 | Cite as

Murine M2-10B4 and SL/SL cell lines differentially affect the balance between CD34+ cell expansion and maturation

  • Steffen Koschmieder
  • Gesine Bug
  • Bernd Schröder
  • Tanja Roßmanith
  • Wolf-Karsten Hofmann
  • Uwe Kalina
  • Dieter Hoelzer
  • Oliver Gerhard Ottmanna
Review Article


The ability of bone marrow stroma to modulate hematopoietic progenitor cell expansion is of considerable interest for gene transfer strategies and transplantation of limited stem cell numbers.We compared the capacity of 2 murine stromal cell lines to affect the balance between maturation and proliferation of human CD34+ cells in short-term expansion cultures. In 7-day serum-free cultures, cytokine-induced amplification of granulocyte-macrophage colony-forming cells (CFC-GM), erythroid burst-forming units (BFU-E), and total cells was significantly increased by the presence of genetically engineered Sl/Sl and M2-10B4 stromal cells in a 1:1 ratio (Sl/M2 cells) compared with stroma-free cultures (P < .05). Sl/M2 cultures generated 21-fold more mature CD15+ cells than stroma-free cultures, without further amplifying the number of CD34+ cells. The addition of serum led to a further increase of CFC-GM, total cells, and CD15+ cells, whereas BFU-E were no longer maintained. Pure Sl/Sl stromal layers were likewise superior to stroma-free cultures in expansion of CD34+ cells and total cells when serum was present. However, the differentiation of CD34+ cells was less pronounced in Sl/Sl cultures compared with Sl/M2 layers, as demonstrated by a lower content of CD15+ cells. Neutralization experiments revealed differential contributions of Flt3 ligand and thrombopoietin to the support of total cell and CFC expansion by Sl/M2 and Sl/Sl stromal feeders.

Key words

CD34+ cells M2-10B4 Sl/Sl Bone marrow stroma Stem cell expansion 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Dorshkind K. Regulation of hemopoiesis by bone marrow stromal cells and their products.Annu Rev Immunol. 1990;8:111–137.CrossRefPubMedGoogle Scholar
  2. 2.
    Aiuti A, Friedrich C, Sieff CA, Gutierrez-Ramos JC. Identification of distinct elements of the stromal microenvironment that control human hematopoietic stem/progenitor cell growth and differentiation.Exp Hematol. 1998;26:143–157.PubMedGoogle Scholar
  3. 3.
    Dexter TM, Spooncer E. Growth and differentiation in the hemopoietic system.Annu Rev Cell Biol. 1987;3:423–441.CrossRefPubMedGoogle Scholar
  4. 4.
    Cashman JD, Clark-Lewis I, Eaves AC, Eaves CJ. Differentiation stage-specific regulation of primitive human hematopoietic progenitor cycling by exogenous and endogenous inhibitors in an in vivo model.Blood. 1999;94:3722–3729.PubMedGoogle Scholar
  5. 5.
    Ziegler BL, Kanz L. Expansion of stem and progenitor cells.Curr Opin Hematol. 1998;5:434–440.CrossRefPubMedGoogle Scholar
  6. 6.
    Bennaceur-Griscelli A, Tourino C, Izac B, Vainchenker W, Coulombel L. Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38 (low/neg) human bone marrow cells.Blood. 1999;94:529–538.PubMedGoogle Scholar
  7. 7.
    Brandt JE, Bartholomew AM, Fortman JD, et al. Ex vivo expansion of autologous bone marrow CD34(+) cells with porcine microvascular endothelial cells results in a graft capable of rescuing lethally irradiated baboons.Blood. 1999;94:106–113.PubMedGoogle Scholar
  8. 8.
    Breems DA, Blokland EA, Siebel KE, Mayen AE, Engels LJ, Ploemacher RE. Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells.Blood. 1998;91:111–117.PubMedGoogle Scholar
  9. 9.
    Thiemann FT, Moore KA, Smogorzewska EM, Lemischka IR, Crooks GM. The murine stromal cell line AFT024 acts specifically on human CD34+ CD38- progenitors to maintain primitive function and immunophenotype in vitro.Exp Hematol. 1998;26:612–619.PubMedGoogle Scholar
  10. 10.
    Hogge DE, Lansdorp PM, Reid D, Gerhard B, Eaves CJ. Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor.Blood. 1996;88:3765–3773.PubMedGoogle Scholar
  11. 11.
    Andrews RG, Briddell RA, Hill R, Gough M, McNiece IK. Engraftment of primates with G-CSF mobilized peripheral blood CD34+ progenitor cells expanded in G-CSF, SCF and MGDF decreases the duration and severity of neutropenia [In Process Citation].Stem Cells. 1999;17:210–218.CrossRefPubMedGoogle Scholar
  12. 12.
    Bernstein ID, Andrews RG, Zsebo KM. Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+ lin- cells, and the generation of colony-forming cell progeny from CD34+ lin- cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor.Blood. 1991;77:2316–2321.PubMedGoogle Scholar
  13. 13.
    Haylock DN, Horsfall MJ, Dowse TL, et al. Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand.Blood. 1997;90:2260–2272.PubMedGoogle Scholar
  14. 14.
    Gabbianelli M, Pelosi E, Montesoro E, et al. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors.Blood. 1995;86:1661–1670.PubMedGoogle Scholar
  15. 15.
    Hestdal K, Jacobsen SE, Ruscetti FW, Longo DL, Boone TC, Keller JR. Increased granulopoiesis after sequential administration of transforming growth factor-β 1 and granulocyte-macrophage colony-stimulating factor.Exp Hematol. 1993;21:799–805.PubMedGoogle Scholar
  16. 16.
    Jacobsen SE, Keller JR, Ruscetti FW, Kondaiah P, Roberts AB, Falk LA. Bidirectional effects of transforming growth factor β (TGF-beta) on colony-stimulating factor-induced human myelopoiesis in vitro: differential effects of distinct TGF-β isoforms.Blood. 1991;78:2239–2247.PubMedGoogle Scholar
  17. 17.
    Ottmann OG, Pelus LM. Differential proliferative effects of transforming growth factor-β on human hematopoietic progenitor cells.J Immunol. 1988;140:2661–2665.PubMedGoogle Scholar
  18. 18.
    Murray LJ, Young JC, Osborne LJ, Luens KM, Scollay R, Hill BL. Thrombopoietin, flt3, and kit ligands together suppress apoptosis of human mobilized CD34+ cells and recruit primitive CD34+ Thy-1+ cells into rapid division.Exp Hematol. 1999;27:1019–1028.CrossRefPubMedGoogle Scholar
  19. 19.
    Ratajczak MZ, Ratajczak J, Marlicz W, et al. Recombinant human thrombopoietin (TPO) stimulates erythropoiesis by inhibiting erythroid progenitor cell apoptosis.Br J Haematol. 1997;98:8–17.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2001

Authors and Affiliations

  • Steffen Koschmieder
    • 1
  • Gesine Bug
  • Bernd Schröder
    • 2
  • Tanja Roßmanith
    • 1
  • Wolf-Karsten Hofmann
    • 1
  • Uwe Kalina
    • 1
  • Dieter Hoelzer
    • 1
  • Oliver Gerhard Ottmanna
    • 1
  1. 1.Division of Hematology, Department of Internal Medicine IIIJohann Wolfgang Goethe-University HospitalFrankfurt/MainGermany
  2. 2.MainGen Biotechnologie GmbHFrankfurt/MainGermany

Personalised recommendations